Cargando…
Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1
The prevention of metastasis is a central goal of cancer therapy. Caveolin-1 (Cav-1) is a structural membrane and scaffolding protein shown to be a key regulator of late-stage breast cancer metastasis. However, therapeutic strategies targeting Cav-1 are still lacking. Here, we demonstrate that the p...
Autores principales: | Jiang, Ying, Senyuk, Vitalyi, Ma, Ke, Chen, Hui, Qin, Xiang, Li, Shun, Liu, Yiyao, Gentile, Saverio, Minshall, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368491/ https://www.ncbi.nlm.nih.gov/pubmed/35954304 http://dx.doi.org/10.3390/cells11152461 |
Ejemplares similares
-
Compensatory expression of NRF2-dependent antioxidant genes is required to overcome the lethal effects of Kv11.1 activation in breast cancer cells and PDOs
por: Senyuk, Vitalyi, et al.
Publicado: (2021) -
Effects of the Small Molecule HERG Activator NS1643 on Kv11.3 Channels
por: Bilet, Arne, et al.
Publicado: (2012) -
Molecular Activation of the Kv11.1 Channel Reprograms EMT in Colon Cancer by Inhibiting TGFβ Signaling via Activation of Calcineurin
por: Eskandari, Najmeh, et al.
Publicado: (2021) -
Inverse Modulation of Neuronal K(v)12.1 and K(v)11.1 Channels by 4-Aminopyridine and NS1643
por: Dierich, Marlen, et al.
Publicado: (2018) -
Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer
por: Fukushiro-Lopes, Daniela F., et al.
Publicado: (2017)